Airway Ultrasound Versus Mallampati Score as a Predictor of Difficult Direct Laryngoscopy in Obese Patients

Sponsor
Ain Shams University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06057818
Collaborator
(none)
60
6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the ability of pre-operative ultrasound assessment of neck anatomy in predicting difficult laryngoscopy in obese patients undergoing elective surgery requiring tracheal intubation and comparing it to conventional methods as the Mallampati score in anticipating difficult laryngoscopy.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    All patients enrolled in the study will be consented by written and informed consent to do the airway ultrasound before induction.

    During pre-anesthetic evaluation of the patients, demographic variables will be collected from each patient and clinical screening tests to predict difficult airway will be performed in the form of Mallampati score sitting in neutral position.

    The patient will be admitted to the pre-anesthesia care unit, attended by anesthesiologist experienced in ultrasound.

    The ultrasound will be done with the patients seated, head held in neutral position, using the linear probe 13-6i of SonoSite model M-Turbo c with 13-6Mega Hertz frequency, Preoperative ultrasonographic airway assessment will be performed for all patients in the study, Patients will be explained about the procedure before starting the study.

    Operator will position himself on the right side of the patient, holding the ultrasound transducer in the right hand, the transducer will be placed transversely just above the suprasternal notch to visualize the tracheal cartilage, a horseshoe shaped hypoechoic structure, if tracheal deviation is present, the transducer might need to be moved laterally to locate the trachea and its position should be marked out with a pen, the transducer will be moved cephalad to inspect the remaining structures.

    The probe will be placed in the transverse axis, ultrasound distances will be measured as the distance from the hyoid bone to skin surface, the distance from skin to anterior commissure of the vocal cords and the distance from skin to the trachea at the level of the suprasternal notch.

    All measurements will be done using the ultrasound measure and pointing in mm, gain and depth will be adjusted accordingly to obtain best view.

    Difficult intubation tray and settings will be available and ready before induction.

    Patients will be taken to the operating room and will be monitored by American Society of Anesthesiologists standard monitors: ECG, noninvasive blood pressure, pulse oximetry, capnography then after pre-oxygenation with fraction of inspired oxygen : 100% for 3 min, intravenous (IV) midazolam 1 mg and fentanyl 1 µg/kg, anesthesia will be induced with injection of propofol 2 mg/kg. After muscle relaxation with injection of rocuronium 0.8 mg/kg IV and ventilation with oxygen and sevoflurane 1.5% for 3 min, direct laryngoscopy will be done by attending anesthesiologist (with more than 2 years of experience post-qualification) using an appropriate size curved Macintosh blade, and the modified Cormack-Lehane (CL) laryngoscopic grade will be evaluated and documented. The correct positioning of the endotracheal tube will be confirmed via capnography and bilateral auscultation of lungs.

    The view of the glottis aperture will be assessed using the modified Cormack Lehane scale at which grading of 2b, 3 and 4 will be considered a difficult intubation view for the patient.

    The intubating anesthesiologist will not be involved in preoperative clinical and sonographic airway assessment. Therefore, he will be blinded to the findings of preoperative airway evaluation.

    Anesthesia will be maintained by sevoflurane, booster doses of rocuronium and fentanyl as needed.

    Patients are assessed regarding:
    • Mallampati score

    • Distance from skin to vocal cords

    • Distance from skin to anterior aspect of trachea at level of suprasternal notch

    • Distance from skin to hyoid bone

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Airway Ultrasound Versus Mallampati Score as a Predictor of Difficult Direct Laryngoscopy in Obese Patients an Observational Study
    Anticipated Study Start Date :
    Oct 1, 2023
    Anticipated Primary Completion Date :
    Mar 1, 2024
    Anticipated Study Completion Date :
    Apr 1, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Comparison between the Mallampati score and the airway ultrasound [6 months]

      Comparison between the Mallampati score and the airway ultrasound measurements in the prediction of difficult intubation in obese patients

    Secondary Outcome Measures

    1. comparison between each airway ultrasound measurement [6 months]

      The sensitivity and specificity of each airway ultrasound measurement to anticipate difficult intubation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Both sexes

    2. Age from18 to 60 years old

    3. With an American Society of Anesthesiologists physical status classification score of I to III,

    4. Scheduled for elective surgical procedure requiring endotracheal intubation

    5. Body mass index more than 30 kg/m2.

    Exclusion Criteria:
    1. Patient refusal

    2. Emergency surgery

    3. Patients with history of airway or neck surgery

    4. Neck mobility abnormalities

    5. Syndromatic patients

    6. Pre-existing airway malformations or pathology like facial or cervical fractures, maxillofacial abnormalities, cervical tumors or goiter.

    7. History of difficult intubation.

    8. Patients with tracheostomy tubes.

    9. Pregnant patients.

    10. Body mass index less than 30 kg/m2.

    11. ASA IV or above patients.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Ain Shams University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sherif Hany Adly Loka, assistant lecturer, Ain Shams University
    ClinicalTrials.gov Identifier:
    NCT06057818
    Other Study ID Numbers:
    • MD99/2023
    First Posted:
    Sep 28, 2023
    Last Update Posted:
    Sep 28, 2023
    Last Verified:
    Sep 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Sep 28, 2023